Christopher J Porter

10PUBLICATIONS
22CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Haematological tumoursMedical mycologyPsychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 02, 2026
Publisher Correction: An OTX2-PAX3 signaling axis regulates Group 3 medulloblastoma cell fate.

Jamie Zagozewski, Ghazaleh M Shahriary, Ludivine Coudière Morrison

|May 28, 2025
miR-486-5p Inhibits eNOS and Angiogenesis in Cultured Endothelial Cells by Targeting MAML3.

|Jul 18, 2024
A group 3 medulloblastoma stem cell program is maintained by OTX2-mediated alternative splicing.

Olivier Saulnier, Jamie Zagozewski, Lisa Liang

|Sep 19, 2023
Cross-species analysis of SHH medulloblastoma models reveals significant inhibitory effects of trametinib on tumor progression.

Stephanie Borlase, Alexandria DeCarlo, Ludivine Coudière-Morrison

|Jul 14, 2022
Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression.

Jamie Zagozewski, Stephanie Borlase, Brent J Guppy

|Jul 21, 2020
An OTX2-PAX3 signaling axis regulates Group 3 medulloblastoma cell fate.

Jamie Zagozewski, Ghazaleh M Shahriary, Ludivine Coudière Morrison

Pageof 2

Frequent Collaborators

5 joint publications

Tamra E Werbowetski-Ogilvie

4 joint publications

Olivier Saulnier

4 joint publications

Vijay Ramaswamy

3 joint publications

Michael D Taylor